Cargando…

Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice

The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group),...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Ming-He, Xia, Jie-Yu, Wang, Zi-Ling, Hu, Wen-Xu, Fan, Yan-Ling, Jia, Dao-Yong, Li, Jing, Jing, Peng-Wei, Wang, Lu, Wang, Ya-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200997/
https://www.ncbi.nlm.nih.gov/pubmed/30402153
http://dx.doi.org/10.3892/etm.2018.6727
_version_ 1783365433075695616
author Xiao, Ming-He
Xia, Jie-Yu
Wang, Zi-Ling
Hu, Wen-Xu
Fan, Yan-Ling
Jia, Dao-Yong
Li, Jing
Jing, Peng-Wei
Wang, Lu
Wang, Ya-Ping
author_facet Xiao, Ming-He
Xia, Jie-Yu
Wang, Zi-Ling
Hu, Wen-Xu
Fan, Yan-Ling
Jia, Dao-Yong
Li, Jing
Jing, Peng-Wei
Wang, Lu
Wang, Ya-Ping
author_sort Xiao, Ming-He
collection PubMed
description The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group), where the mice were intraperitoneally administrated with D-gal (120 mg/kg/day for 42 days); ii) D-gal + Rg1 group where the mice were treated with 120 mg/kg/day D-gal for 42 days and with Rg1 at a dose of 20 mg/kg/day for 35 days. The first dose of Rg1 was administered on the 8th day of treatment with D-gal; and iii) the normal control group, where the mice were injected with an equal volume of saline for 42 days. The day following the final injections in all groups, peripheral blood was collected and serum was prepared to measure the contents of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBiL), advanced glycation end products (AGEs) and 8-hydroxy-2 deoxyguanosine (8-OH-dG). Liver tissue homogenates were prepared to measure the contents of malondialdehyde (MDA) and glutathione (GSH), and the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Paraffin section were prepared to observe the microscopic structure of the liver. Transmission electron microscopy was used to observe the ultrastructure of hepatocytes. Frozen section were prepared and stained with senescence-associated β-galactosidase to detect the relative optical density value of senescence-associated markers. Compared with the D-gal group, the contents of AST, ALT, TBiL, AGEs and MDA significantly decreased in the D-gal + Rg1 group, while the activities of SOD and GSH-Px markedly increased, and liver injury and degenerative alterations of hepatocytes were reduced. Administration of Rg1 induced a protective effect on D-gal-induced liver injury in mice by inhibiting the oxidative stress, reducing DNA damage and decreasing the AGE content.
format Online
Article
Text
id pubmed-6200997
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-62009972018-11-06 Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice Xiao, Ming-He Xia, Jie-Yu Wang, Zi-Ling Hu, Wen-Xu Fan, Yan-Ling Jia, Dao-Yong Li, Jing Jing, Peng-Wei Wang, Lu Wang, Ya-Ping Exp Ther Med Articles The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group), where the mice were intraperitoneally administrated with D-gal (120 mg/kg/day for 42 days); ii) D-gal + Rg1 group where the mice were treated with 120 mg/kg/day D-gal for 42 days and with Rg1 at a dose of 20 mg/kg/day for 35 days. The first dose of Rg1 was administered on the 8th day of treatment with D-gal; and iii) the normal control group, where the mice were injected with an equal volume of saline for 42 days. The day following the final injections in all groups, peripheral blood was collected and serum was prepared to measure the contents of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBiL), advanced glycation end products (AGEs) and 8-hydroxy-2 deoxyguanosine (8-OH-dG). Liver tissue homogenates were prepared to measure the contents of malondialdehyde (MDA) and glutathione (GSH), and the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Paraffin section were prepared to observe the microscopic structure of the liver. Transmission electron microscopy was used to observe the ultrastructure of hepatocytes. Frozen section were prepared and stained with senescence-associated β-galactosidase to detect the relative optical density value of senescence-associated markers. Compared with the D-gal group, the contents of AST, ALT, TBiL, AGEs and MDA significantly decreased in the D-gal + Rg1 group, while the activities of SOD and GSH-Px markedly increased, and liver injury and degenerative alterations of hepatocytes were reduced. Administration of Rg1 induced a protective effect on D-gal-induced liver injury in mice by inhibiting the oxidative stress, reducing DNA damage and decreasing the AGE content. D.A. Spandidos 2018-11 2018-09-11 /pmc/articles/PMC6200997/ /pubmed/30402153 http://dx.doi.org/10.3892/etm.2018.6727 Text en Copyright: © Xiao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Xiao, Ming-He
Xia, Jie-Yu
Wang, Zi-Ling
Hu, Wen-Xu
Fan, Yan-Ling
Jia, Dao-Yong
Li, Jing
Jing, Peng-Wei
Wang, Lu
Wang, Ya-Ping
Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
title Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
title_full Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
title_fullStr Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
title_full_unstemmed Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
title_short Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
title_sort ginsenoside rg1 attenuates liver injury induced by d-galactose in mice
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200997/
https://www.ncbi.nlm.nih.gov/pubmed/30402153
http://dx.doi.org/10.3892/etm.2018.6727
work_keys_str_mv AT xiaominghe ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT xiajieyu ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT wangziling ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT huwenxu ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT fanyanling ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT jiadaoyong ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT lijing ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT jingpengwei ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT wanglu ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice
AT wangyaping ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice